July 15 (Reuters) - Genetic Technologies Ltd (GTG) :
- GENETIC TECHNOLOGIES PROVIDES UPDATE ON COVID-19 DISEASE SEVERITY TEST
- GENETIC TECHNOLOGIES LTD - FILED A PROVISIONAL PATENT FOR ITS COVID-19 SEVERITY RISK TEST WITH PATENT OFFICE IN AUSTRALIA
- GENETIC TECHNOLOGIES - IN DISCUSSIONS WITH INTERNATIONAL BIOBANKS AND CLINICAL LABORATORIES TO SOURCE AN INDEPENDENT CROSS-VALIDATION DATASET
- GENETIC TECHNOLOGIES LTD - OPTIONS FOR CLINICAL RISK MODEL CURRENTLY BEING EVALUATED
- GENETIC TECHNOLOGIES LTD - COMMENCED ORDERING ITS FIRST SNP ARRAY PANEL FROM US-BASED THERMO FISHER SCIENTIFIC
- GENETIC TECHNOLOGIES LTD - CONFIRMED CAPACITY TO SCALE UP PRODUCTION FOR GLOBAL-ROLL OUT OF COVID-19 SEVERITY RISK TEST WITH MAJOR MANUFACTURERS
July 15 (Reuters) - Genetic Technologies Ltd (GTG) : GENETIC...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| GTG (ASX) Chart |
Day chart unavailable